Related Experiment Video

Updated: Jun 9, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer

Stanislav Zelivianski1, Anne Cooley, Ron Kall

  • 1Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

Molecular Cancer Research : MCR
|August 26, 2010
PubMed

Insights

Overexpression of cyclin D1 in breast cancer promotes cell growth by inhibiting Smad3 activity via CDK4 phosphorylation. Inhibiting this phosphorylation restores cell cycle arrest, suggesting CDK4 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Smad3, a key mediator of transforming growth factor β signaling, induces G1 arrest in breast cancer cells.
  • Cyclin D1/cyclin-dependent kinase 4 (CDK4) promotes cell cycle progression and can inhibit Smad3 activity through phosphorylation.

Purpose of the Study:

  • To investigate if cyclin D1 overexpression drives tumorigenesis in breast cancer by inhibiting Smad3 via CDK4 phosphorylation, thereby releasing G1 arrest.
  • To explore the therapeutic potential of targeting CDK4 in cyclin D1-overexpressing breast cancers.

Main Methods:

  • Real-time quantitative reverse transcription-PCR and immunoblotting to assess protein expression.
  • Transfection of breast cancer cells with wild-type (WT) Smad3 or Smad3 mutants (M) with altered CDK phosphorylation sites.
  • Treatment with CDK4 inhibitor or cdk4 small interfering RNA (siRNA) to assess Smad3 activity and cell cycle control.

Main Results:

  • Smad3 mutants (T8, T178, 4M, 5M) exhibited higher transcriptional activity compared to WT Smad3.
  • Inhibition of CDK4 (via inhibitor or siRNA) increased Smad3 transcriptional activity, particularly in cells with Smad3 mutants.
  • Treatment with CDK4 inhibitor in cells with Smad3 T8 or T178 mutants led to an increased G1 cell population.

Conclusions:

  • CDK4-mediated phosphorylation of Smad3 inhibits its transcriptional activity and blocks cell cycle arrest in breast cancer.
  • Releasing this inhibition by targeting CDK4 activity can restore Smad3 function and induce G1 arrest.
  • Targeting CDK4 may be a viable therapeutic strategy for breast cancers overexpressing cyclin D1.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.